• Home
  • News
  • BUSINESS VISIT OF THE ALMATY DELEGATION TO SHENZHEN, CHINA 🇰🇿🇨🇳

BUSINESS VISIT OF THE ALMATY DELEGATION TO SHENZHEN, CHINA 🇰🇿🇨🇳

8 February 2026
BUSINESS VISIT OF THE ALMATY DELEGATION TO SHENZHEN, CHINA 🇰🇿🇨🇳

During a working trip to the People’s Republic of China, the Almaty delegation visited Shenzhen — one of the world’s key centers for information technology and innovation development.

During the visit, the delegation held a meeting with the Shenzhen Entrepreneurs Association and the leadership of the organization responsible for protecting the rights and interests of foreign-invested enterprises. The parties discussed prospects for expanding bilateral cooperation, exchanging experience in IT development, and investment interaction.

The Almaty delegation proposed exploring the possibility of opening a Shenzhen city representative office in Almaty, connecting China’s southern IT capital with a leading business and technology hub in Central Asia. This initiative aims to strengthen partnerships, attract technology companies, and launch joint projects.

An open meeting with major regional entrepreneurs was organized with the support of the Shenzhen city administration. During the event, the delegation presented Almaty’s investment potential, current government support measures, and promising areas for cooperation. Special attention was given to the IT park construction project within the master plan for the development of Almaty’s polycenters, which attracted interest from investors.

At the end of the program, the delegation visited several innovative enterprises in Shenzhen to learn about modern technological solutions and advanced approaches to business development.

Other news

In Almaty, as part of the environmental initiative “Taza Kazakhstan,” an event was held that once again proved that even…

April 4, 2026

The Chairman of the Board of Almaty Invest held a working meeting with the Consul General of the Republic of…

April 2, 2026

The Board of Almaty Invest held a meeting with a major Chinese manufacturer of generic medicines and pharmaceutical products –…

April 1, 2026